With the closing of its $330 million Fund V, Santé Ventures is doubling down on a strategy that blends disciplined venture investing with a deep commitment to improving patient care. Through the complementary medtech leadership of Managing Directors James Eadie, MD, and Dennis McWilliams, the firm is helping shape the next generation of medtech, healthtech, and biotech innovation at a moment when venture markets are being redefined.
In venture capital, the most important decisions often happen long before the market notices.
Investors sit across the table from founders with little more than a prototype, an unmet clinical need, and a belief that medicine can be practiced differently. The risks are obvious, the timelines are long, and the outcomes are never guaranteed. Yet this is precisely where Santé Ventures has chosen to operate for two decades.
The recent closing of its fifth fund at $330 million is the largest raise in its history. The Austin-based firm is doubling down on a strategy built on early conviction, disciplined investing, and the belief that the most transformative companies across medtech, healthtech, and biotech begin long before they appear on the industry’s radar.
For Dennis McWilliams and James Eadie, MD, Managing Directors at Santé, the milestone reflects both progress and continuity.
Ask Santé what makes it unique, and McWilliams and Eadie say it's their dedication to remaining an early-stage investor in medtech.
That may sound simple. It is not.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy | Your Privacy Choices | Delete my Data